Biolase, Inc.
BIOL
BIOL was delisted on the 18th of June, 2024.
30 hedge funds and large institutions have $19.5M invested in Biolase, Inc. in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 7 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
6% less funds holding
Funds holding: 32 → 30 (-2)
22% less capital invested
Capital invested by funds: $25.1M → $19.5M (-$5.59M)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Birchview Capital
Burlington,
Vermont
|
+$87.4K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$76.5K |
| 3 |
TMC
Trellus Management Company
Delray Beach,
Florida
|
+$54.6K |
| 4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$43.7K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$10.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$1.58M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
-$1.23M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$1.01M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$270K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$255K |
BIOL Hedge Fund Activity: Q4 2015 in Review
30 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q4 2015, worth a combined $19.5M — down 22% from $25.1M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of BIOL and 5 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 4 added.
The largest buyer was Birchview Capital, adding an estimated $87.4K. The largest seller was Visium Asset Management, exiting entirely with an estimated $1.58M sold.
- 30 institutional investors held Biolase, Inc. (BIOL) as of Q4 2015, down from 32 in Q3 2015.
- Funds reported $19.5M of Biolase, Inc. stock for Q4 2015, down 22% quarter-over-quarter.
- 5 funds opened new Biolase, Inc. positions in Q4 2015 and 7 closed out, a net change of -2 holders.
- The largest Biolase, Inc. buyer in Q4 2015 was Birchview Capital, an estimated $87.4K added.
- The largest Biolase, Inc. seller in Q4 2015 was Visium Asset Management, an estimated $1.58M sold.
Based on aggregated 13F filings for Q4 2015.